Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Pathway Data Analysis Platform to Exelixis

NEW YORK , May 13 (GenomeWeb News) — GeneGo has licensed its MetaCore pathway analysis and datamining platform to Exelixis, the St. Joseph, Mich. -based company said today.

 

MetaCore allows researcher to mine high-throughput experimental data in the context of biological networks, pathways, and human diseases.

 

Earlier this week , GeneGo licensed its MetaCore and MetaBase products to Procter & Gamble Pharmaceuticals.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.